IL2 and primary cutaneous T-cell non-Hodgkin lymphoma: Significantly, IL-15 but not IL-2 levels are elevated in MAC-2A cells (not shown) and in CTCL patients (Supplementary Figure 3), further supporting a clinical role for IL-15 signaling in CTCL progression.